Business Context and Reporting Period
Company: ACME UNITED CORP
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2000
Business Overview: The company manufactures and distributes office products, with sales historically seasonal, peaking in the second and third quarters due to the back-to-school season.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2000 | Six Months Ended June 30, 1999 |
|---|---|---|
| Net Sales | $18,242,000 | $18,121,000 |
| Gross Profit | $6,235,000 (34.2% margin) | $4,818,000 (26.6% margin) |
| Net Income (Continuing Ops) | $621,000 | ($417,000) Loss |
| Net Income (Total) | $621,000 | $1,882,000 (Includes discontinued ops) |
| Diluted EPS (Continuing Ops) | $0.17 | ($0.12) |
| Cash and Equivalents (End of Period) | $9,000 | $33,000 |
| Net Cash Used in Operating Activities | ($2,180,000) | ($2,610,000) |
| Total Debt (Current + Long Term) | $9,246,000 | $7,044,000 |
| Working Capital | $7,875,000 | $6,956,000 |
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of $621,000 from continuing operations for the six months ended June 30, 2000, compared to a net loss of $417,000 in the same period in 1999. The 1999 prior period included a significant gain of $2,101,000 from the sale of the medical division, which is classified as discontinued operations.
- Gross Margin Expansion: Gross margin improved significantly to 34.2% in 2000 from 26.6% in 1999. Management attributes this to resourcing scissor products to Asia, aggressive purchasing, and improved manufacturing efficiencies in the USA.
- Revenue Growth: Net sales increased 1% year-over-year to $18.2 million. Domestic sales were up 2% for the six-month period, while international sales were down 2% due to weakness in Canada and Germany, partially offset by growth in England.
- Debt Levels: Total debt increased by approximately $2.2 million to $9.2 million, driven by seasonal demand and a new refinancing agreement.
- Cash Flow: Operating cash flow remained negative ($2.18 million used), primarily due to increases in accounts receivable ($2.0 million) and inventories ($1.0 million). However, this was an improvement over the $2.61 million used in the prior year.
Guidance, Outlook, and Risks
- Liquidity and Financing: On January 19, 2000, the company entered a new loan agreement allowing borrowings up to $11.5 million based on receivables and inventory. As of June 30, 2000, there was $1 million in excess availability. Management expects cash generated from operations and available credit to be sufficient for 2000 operations.
- Interest Rate Management: On August 7, 2000, the company entered an interest rate swap to fix the rate at 10.18% for $3.5 million of debt.
- Covenants: The company is subject to financial covenants regarding tangible net worth, debt service coverage, and fixed charge coverage. It was in compliance as of June 30, 2000.
- Legal and Environmental Contingencies: The company is involved in environmental matters and lawsuits regarding latex products (distributed but not manufactured). Five lawsuits remain in preliminary stages. Management believes there will be no material adverse impact on financial position.
- Forward-Looking Risks: Risks include the ability to manage growth and inventory, changes in plans/strategies, and general market uncertainties.
Investor Verification Checklist
- Discontinued Operations Impact: Verify the exclusion of the $2.1 million gain from the 1999 medical division sale when comparing year-over-year profitability.
- Working Capital Trends: Monitor the significant increase in Accounts Receivable ($2.0M) and Inventories ($1.0M) which drove negative operating cash flow despite improved net income.
- Debt Covenants: Confirm continued compliance with the new loan agreement's tangible net worth and coverage ratios.
- International Exposure: Assess the sustainability of sales declines in Canada and Germany versus growth in England.
- Legal Exposure: Track the status of the five remaining latex product lawsuits to ensure no material liability emerges.